Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC

Clinical trial NCT04081688 · TERMINATED

Trial details

NCT number: NCT04081688
Sponsor: Rutgers, The State University of New Jersey
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Start date: 2019-09-11
Primary completion: 2022-04-27
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.